6-(4-Methyl-1-piperazinyl)morphanthridine (Perlapine), a new tricyclic compound with sedative and sleep-promoting properties. A pharmacological study.
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects; D002415:Cats; D003864:Depression, Chemical; D003984:Dibenzazepines / Q000494:pharmacology*; D004569:Electroencephalography; D006993:Hypnotics and Sedatives / Q000494:pharmacology*; D051379:Mice; D009043:Motor Activity / Q000187:drug effects*; D009125:Muscle Relaxants, Central / Q000494:pharmacology; D009567:Nitrazepam / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology*; D051381:Rats; D012154:Reticular Formation / Q000187:drug effects; D012890:Sleep / Q000187:drug effects; D012894:Sleep Stages; D013687:Telencephalon; D014149:Tranquilizing Agents / Q000494:pharmacology
D003984:Dibenzazepines; D006993:Hypnotics and Sedatives; D009125:Muscle Relaxants, Central; D010879:Piperazines; D014149:Tranquilizing Agents; C003910:perlapine; D009567:Nitrazepam; D010634:Phenobarbital